A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

PHASE2CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Weight ManagementTreatment Of Obesity
Interventions
DRUG

CE-326,597 100 mg QD

Administered orally, once daily with morning meal for duration of trial (84 days).

DRUG

CE-326,597 50 mg QD

Administered orally, once daily with morning meal for duration of trial (84 days).

DRUG

CE-326,597 25 mg QD

Administered orally, once daily with morning meal for duration of trial (84 days).

DRUG

Placebo

Placebo to match CE-326,597 tablets to be administered orally, once daily with morning meal for duration of trial (84 days).

DRUG

CE-326,597 5mg QD

Administered orally, once daily with morning meal for duration of trial (84 days).

Trial Locations (54)

1431

Pfizer Investigational Site, Sofia

1606

Pfizer Investigational Site, Sofia

5800

Pfizer Investigational Site, Pleven

6000

Pfizer Investigational Site, Stara Zagora

15706

Pfizer Investigational Site, Santiago de Compostela

19446

Pfizer Investigational Site, Lansdale

20817

Pfizer Investigational Site, Bethesda

23294

Pfizer Investigational Site, Richmond

28040

Pfizer Investigational Site, Madrid

30094

Pfizer Investigational Site, Conyers

30342

Pfizer Investigational Site, Atlanta

33143

Pfizer Investigational Site, Miami

33401

Pfizer Investigational Site, West Palm Beach

34471

Pfizer Investigational Site, Ocala

39202

Pfizer Investigational Site, Jackson

41013

Pfizer Investigational Site, Seville

44340

Pfizer Investigational Site, Guadalajara

44656

Pfizer Investigational Site, Ladrón de Guevara

45249

Pfizer Investigational Site, Cincinnati

55318

Pfizer Investigational Site, Chaska

55455

Pfizer Investigational Site, Minneapolis

57702

Pfizer Investigational Site, Rapid City

58103

Pfizer Investigational Site, Fargo

60607

Pfizer Investigational Site, Chicago

60654

Pfizer Investigational Site, Chicago

64460

Pfizer Investigational Site, Monterrey

66212

Pfizer Investigational Site, Overland Park

75231

Pfizer Investigational Site, Dallas

75246

Pfizer Investigational Site, Dallas

77701

Pfizer Investigational Site, Beaumont

77706

Pfizer Investigational Site, Beaumont

83404

Pfizer Investigational Site, Idaho Falls

85023

Pfizer Investigational Site, Phoenix

89052

Pfizer Investigational Site, Henderson

89101

Pfizer Investigational Site, Las Vegas

89117

Pfizer Investigational Site, Las Vegas

91950

Pfizer Investigational Site, National City

92128

Pfizer Investigational Site, San Diego

93720

Pfizer Investigational Site, Fresno

96814

Pfizer Investigational Site, Honolulu

V3K 3P4

Pfizer Investigational Site, Coquitlam

R3a 1R9

Pfizer Investigational Site, Winnipeg

R3E 3P4

Pfizer Investigational Site, Winnipeg

N6A 4V2

Pfizer Investigational Site, London

H7T 2P5

Pfizer Investigational Site, Laval

H3A 1A1

Pfizer Investigational Site, Montreal

560 052

Pfizer Investigational Site, Bangalore

452 001

Pfizer Investigational Site, Indore

440 012

Pfizer Investigational Site, Nagpur

422 013

Pfizer Investigational Site, Nashik

00716

Pfizer Investigational Site, Ponce

00909

Pfizer Investigational Site, San Juan

00949

Pfizer Investigational Site, Tao Baja

08036

Pfizer Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY